Difference between revisions of "QIBA PET Amyloid Biomarker Committee Call Summaries"
Jump to navigation
Jump to search
(→2015) |
m (→2017) |
||
(32 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
+ | ==2017== | ||
+ | |||
+ | *[[Media:09_08_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|09.08.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:08_11_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|08.11.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:07_14_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|07.14.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *There are no notes for June, as this call was used for the Nuclear Medicine Coordinating Committee. | ||
+ | |||
+ | *[[Media:05_12_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|05.12.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:04_14_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|04.14.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:03_10_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|03.10.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:02_10_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-esp.FINAL.pdf|02.10.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:01_20_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|01.20.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | ==2016== | ||
+ | |||
+ | *[[Media:11_11_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|11.11.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:10_14_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|10.14.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:09_09_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-DRAFT.pdf|09.09.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:08_12_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|08.12.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:07_08_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|07.08.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:06 10 2016 QIBA Amyloid BC Call Summary-FINAL-ESP.pdf |06.10.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:06 10 2016 QIBA Amyloid BC PowerPoint Slides-AMS.pdf |06.10.2016 QIBA PET Amyloid Biomarker Committee PowerPoint Slides (Dr. Smith)]] | ||
+ | |||
+ | *[[Media:05 13 2016 QIBA Amyloid BC PowerPoint Slides-AMS-2.pdf |05.13.2016 QIBA PET Amyloid Biomarker Committee PowerPoint Slides (Dr. Smith)]] | ||
+ | |||
+ | *[[Media:05 13 2016 QIBA Amyloid BC Call Summary-FINAL-AMS-3.pdf |05.13.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:04 08 2016 QIBA Amyloid BC Call Summary-FINAL.pdf |04.08.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:03 11 2016 QIBA Amyloid BC Call Summary-FINAL-AMS.pdf |03.11.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:02 12 2016 QIBA Amyloid BC Call Summary-FINAL.pdf |02.12.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
+ | *[[Media:01 15 2016 QIBA Amyloid BC Call Summary-FINAL.pdf |01.15.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | |||
==2015== | ==2015== | ||
− | + | *[[Media:12 11 2015 QIBA Amyloid BC Call Summary-FINAL-AMS-ESP.pdf |12.11.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] | |
+ | *[[Media:11 13 2015 QIBA Amyloid BC Call Summary-FINAL.pdf |11.13.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | *[[Media:11 13 2015 QIBA Amyloid BC Call Summary-FINAL-AMS.pdf |11.13.2015 QIBA PET Amyloid Biomarker Committee Meeting Slides]] | ||
+ | *[[Media:10 09 2015 QIBA Amyloid BC Call Summary-FINAL-ESP.pdf |10.09.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | *[[Media:09 11 2015 QIBA Amyloid BC Call Summary-FINAL-ESP.pdf |09.11.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
+ | *[[Media:08 14 2015 QIBA Amyloid BC Call Summary-FINAL-AMS.pdf |08.14.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
*[[Media:07 17 2015 QIBA Amyloid BC Call Summary-FINAL.pdf |07.17.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] | *[[Media:07 17 2015 QIBA Amyloid BC Call Summary-FINAL.pdf |07.17.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
*[[Media:06 19 2015 QIBA PET Amyloid BC Call Summary-FINAL.pdf |06.19.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] | *[[Media:06 19 2015 QIBA PET Amyloid BC Call Summary-FINAL.pdf |06.19.2015 QIBA PET Amyloid Biomarker Committee Call Summary]] |
Latest revision as of 20:19, 11 September 2017
2017
- There are no notes for June, as this call was used for the Nuclear Medicine Coordinating Committee.
2016
2015
- 12.11.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 11.13.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 11.13.2015 QIBA PET Amyloid Biomarker Committee Meeting Slides
- 10.09.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 09.11.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 08.14.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 07.17.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 06.19.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 05.22.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 04.24.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 03.27.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 02.13.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 01.30.2015 QIBA PET Amyloid Biomarker Committee Call Summary